Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Christina Lake CannabisCLCFF -13.50% Equity-to-Asset is 0.48 as of Feb. 2026, which is 8% below its 10-year median of 0.52. The stock has 4 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Christina Lake Cannabis ranks worse than 68.45% on this metric.
Christina Lake Cannabis (OTCPK:CLCFF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Christina Lake Cannabis Equity-to-Asset Related Terms
Christina Lake Cannabis Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Christina Lake Cannabis's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Christina Lake Cannabis Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Christina Lake Cannabis's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Christina Lake Cannabis's Equity-to-Asset falls into.
Christina Lake Cannabis Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Christina Lake Cannabis's Equity to Asset Ratio for the fiscal year that ended in Feb. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Christina Lake Cannabis (CLCFF) has a Equity-to-Asset of 0.48 as of Feb. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Christina Lake Cannabis and its competitors. This is near median its historical median of 0.52. Over the past decade, Christina Lake Cannabis' Equity-to-Asset has ranged from 0.46 to 0.97. According to the industry distribution chart, Christina Lake Cannabis ranks #690 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 68.5%.
Is Christina Lake Cannabis' Equity-to-Asset too high?
Christina Lake Cannabis' current Equity-to-Asset of 0.48 is near median its 10-year median of 0.52. Over the past 10 years, this metric has ranged from a low of 0.46 to a high of 0.97. The Drug Manufacturers industry median Equity-to-Asset is 0.61. Christina Lake Cannabis' value of 0.48 is 21.3% below this industry median. Based on the distribution chart, Christina Lake Cannabis ranks #690 out of 1008 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Christina Lake Cannabis' Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Christina Lake Cannabis ranks #690 out of 1008 companies for Equity-to-Asset. This places Christina Lake Cannabis in the lower half of its industry. The industry median Equity-to-Asset is 0.61. Christina Lake Cannabis' value of 0.48 is 21.3% below this benchmark. Historically, Christina Lake Cannabis' own Equity-to-Asset has ranged from 0.46 to 0.97 over the past decade. While the company's 10-year median is 0.52 vs. the industry median of 0.61, Christina Lake Cannabis has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Christina Lake Cannabis's current Equity-to-Asset of 0.48 is 21.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Christina Lake Cannabis and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Christina Lake Cannabis's current Equity-to-Asset is 0.48, which is near median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Christina Lake Cannabis stock overvalued right now?
Based on GuruFocus' analysis, Christina Lake Cannabis (CLCFF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.01, compared to a current price of $0.02 — trading 73% above its estimated fair value. The current Equity-to-Asset is 0.48, which is near median its 10-year median of 0.52 and 21.3% below the Drug Manufacturers industry median of 0.61. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Christina Lake Cannabis (CLCFF), the current Equity-to-Asset is 0.48 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Christina Lake Cannabis Corp is a licensed producer of cannabis. The company cultivates cannabis using strains specifically developed for outdoor cultivation. It is a producer of high-quality, low-cost, sun-grown cannabis flowers, oil cannabinoids, and hemp-based extracts and derivatives, serving domestic and international markets.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLCFF has been successfully added to your 
